Express Pharma

Laurus Labs completes US FDA audit for Unit 4

0 28

The inspection was carried out from July 8 to 12 July 2019

Laurus Labs, a leading research and development-driven and fully-integrated pharmaceutical company in India, announced that the maiden US FDA audit for its Unit 4 was successfully completed without any observations and no form 483 issued. The inspection was carried out from July 8 to 12 July 2019.

 

 

Leave A Reply

Your email address will not be published.